当前位置:
X-MOL 学术
›
Lancet Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Harnessing stereotactic precision in the fight against primary kidney cancer: time for a randomised trial?
The Lancet Oncology ( IF 51.1 ) Pub Date : 2024-02-26 , DOI: 10.1016/s1470-2045(24)00083-4 Daniel X Yang , Raquibul Hannan
中文翻译:
利用立体定向精度对抗原发性肾癌:是时候进行随机试验了?
更新日期:2024-02-26
The Lancet Oncology ( IF 51.1 ) Pub Date : 2024-02-26 , DOI: 10.1016/s1470-2045(24)00083-4 Daniel X Yang , Raquibul Hannan
中文翻译:
利用立体定向精度对抗原发性肾癌:是时候进行随机试验了?